GeneDx Holdings (WGS) Misses Q1 EPS by 27c ; Offers Guidance

GeneDx Holdings (NASDAQ: WGS) reported Q1 EPS of ($0.28), $0.27 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $102.3 million versus the consensus estimate of $112.45 million.

GUIDANCE:

GeneDx Holdings sees Q2 2026 revenue of $110-112 million, versus the consensus of $130.3 million.

GeneDx Holdings sees FY2026 revenue of $475-490 million, versus the consensus of $550 million.

For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• zSpace, Inc. (ZSPC) Reports Q2 results
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c